Slide 2
Clinical Trials in the Spotlight: How to Solidify Progress Made

ACRO Executive Director, Doug Peddicord, authored an Op-Ed for Morning Consult on the spotlight put on clinical trials during the pandemic, and
what it means for the future of the industry.

Slide Image
Slide 1
Risk-Based Monitoring in Clinical Trials: Increased Adoption Throughout 2020

ACRO released a new analytical report on the takeaways from our 2020 landscape survey of RBM and RBQM implementation.

Slide Image

Responses and Resources for COVID-19

Click here for ACRO’s latest statements on the COVID-19 pandemic.


Read about ACRO’s initiatives, COVID-19 efforts, and more.

Member Innovation Hub

Take a look at how our members are innovating in top focus areas.


Get ACRO’s newsletter to stay informed about our work and the industry.

    News and Comments

    Press Releases

    ACRO Marks 20th Anniversary – And Welcomes New Member

    April 1, 2022

    Washington, DC — On March 16, 2022, ACRO’s Board of Directors was joined by more than 125 clinical research stakeholders – including…

    Press Releases

    2022 Officers and New Member Announcement

    January 21, 2022

    Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Jackie…


    OPINION: Clinical Trials in the Spotlight: How to Solidify the Progress Made

    November 30, 2021

    The below is the Op-Ed authored by ACRO Executive Director, Doug Peddicord for Morning Consult on November 3, 2021. Read the full…


    ACRO Releases Toolkit to Help Advance Decentralized Clinical Trials

    August 11, 2021

    Today, ACRO released its DCT Toolkit, which lays out a vision for how decentralized clinical trials can be planned and executed now…

    Press Releases

    ACRO Applauds Release of Cures 2.0 Draft Legislation

    June 23, 2021

    Washington, DC — The Association of Clinical Research Organizations (ACRO) congratulates Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) on the release…

    Press Releases

    ACRO Releases New Report on the Past, Present, and Future of Risk-Based Monitoring

    May 4, 2021

    Risk-based monitoring (RBM) is a powerful tool for efficiently ensuring patient safety and data integrity in a clinical trial, enhancing overall trial…

    US Regulatory Policy

    Half of all clinical trials occur in the US. ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. More »

    European Advocacy

    ACRO engages with European regulators, connecting its members with critical stakeholders. We support the clinical research industry and provide CRO expertise. More »

    CRO Forum

    ACRO’s CRO Forum is a formal mechanism to enable clinical research organizations to interact with TransCelerate BioPharma Inc. on a range of issues that impact the industry. More »

    Clinical Research Roundtables

    In Europe and the US, ACRO gathers government leaders and key stakeholders to inform, educate and promote the unique contributions of clinical research and technology companies. More »

    Data Protection & Privacy

    ACRO’s Global Data Protection & Privacy Committee advances issues of data privacy, protection and security, and how the industry interprets policies and prepares for upcoming legislation. More »

    Join ACRO and Add Your Voice

    We help create a global regulatory and business environment
    where ACRO members succeed

    ACRO Members